Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: J Cardiovasc Nurs. 2017 Mar-Apr;32(2):171–179. doi: 10.1097/JCN.0000000000000327

Table 1.

Sample Characteristics (N=206)

Total (N = 206) Living alone (n = 53) Living with someone (N = 153) p-value
Age, years 60 (11.6) 61 (11.6) 59 (11.6) 0.187

Female 69 (33.5%) 23 (43.4%) 46 (30.1%) 0.076

Education level, years 13 (3.3) 13 (2.9) 13 (3.4) 0.614

Ethnicity 0.427
 White 159 (77.2%) 43 (81.1%) 116 (75.8%)
 Minority 47 (22.8%) 10 (18.9%) 37 (24.2%)

NYHA class 0.650
 I/II 91 (44.2%) 22 (41.5%) 69 (45.1%)
 III/IV 115 (55.8%) 31 (58.5%) 84 (54.9%)

Ischemic etiology of HF (n=197) 139 (70.6%) 39 (78.0%) 100 (68.0%) 0.027

Chalson Comorbidity Index 3.3 (2.0) 3.7 (2.2) 3.2 (1.9) 0.124

Self-care
 Maintenance 49.6 (22.5) 46.9 (21.5) 50.5 (22.9) 0.314
 Management 54.7 (21.3) 52.6 (20.9) 55.5 (21.4) 0.407
 Confidence 56.5 (22.0) 49.2 (18.7) 59.0 (22.6) 0.005

Depressive Symptoms 6.9 (5.6) 8.0 (5.5) 6.5 (5.6) 0.098

Medications
 ACEI or ARB (n=204) 158 (77.5%) 39 (73.6%) 119 (78.8%) 0.434
 Beta Blocker (n=203) 177 (87.2%) 46 (88.5%) 131 (86.8%) 0.751
 Diuretics (n=203) 154 (75.9%) 40 (75.5%) 114 (76.0%) 0.938
 Antidepressants (n=203) 50 (24.6%) 17 (32.1%) 33 (22.0%) 0.143

Note. Values are mean (SD) or n (%).

NYHA=New York Heart Association; HF= Heart Failure; ACEI = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker